Navigation Links
Blood Antibody May Signal Start of Ovarian Cancer
Date:8/17/2011

By Serena Gordon
HealthDay Reporter

WEDNESDAY, Aug. 17 (HealthDay News) -- Researchers have found an antibody that might someday be useful in identifying women who have a higher risk of ovarian cancer, or possibly diagnosing early ovarian cancer.

This particular antibody, which was detected in blood, develops as an immune system response to a protein called mesothelin. This protein is present in advanced ovarian cancer. Although mesothelin is found in normal tissue, it's found in abundance in ovarian cancer cells.

The current study found that infertile women, who are known to have an increased risk of ovarian cancer, were more likely to have the mesothelin antibody. The researchers also found that women with ovarian cancer were more likely to have this antibody.

"We're taking a novel approach to try to identify earlier biomarkers of ovarian cancer by looking at high-risk women," said study author Judith Luborsky, a professor of pharmacology, obstetrics and gynecology, and preventive medicine at Rush University Medical Center in Chicago.

"This study found that there are antibodies to mesothelin circulating in women that have infertility," noted Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society. Exactly what these findings mean isn't yet clear, however. "Are these women who will develop ovarian cancer? Are these antibodies related to infertility? This research gives us some clues, and leads to many more questions," he said.

As for an individual woman who's currently concerned about ovarian cancer, Lichtenfeld said, "I would be very cautious about drawing any conclusion about the meaning of an elevated antibody level in an individual woman."

Results of the study will be published Aug. 17 in the online version of the journal Cancer Epidemiology, Biomarkers & Prevention.

Almost 22,000 American women are diagnosed with ovarian cancer each year, and more than 15,000 women die each year as a result of this disease, reports the American Cancer Society.

Most women who develop ovarian cancer aren't diagnosed until the disease is advanced. If it's found early, ovarian cancer has a five-year survival rate of 94 percent, according to the cancer society. Two tests that experts hoped would help change that -- a combination of transvaginal ultrasound and a blood test for CA-125, a marker associated with ovarian cancer -- haven't reduced a woman's risk of dying from ovarian cancer, according to a recent study in the Journal of the American Medical Association.

Luborsky and her colleagues wanted to try to find a way to detect early cancer or a screening test for who's at high risk for ovarian cancer before the cancer develops. Testing for mesothelin wouldn't work, because it isn't found at high levels until the cancer is advanced.

So, instead of looking for mesothelin, the researchers looked at a group of 109 infertile women, 28 women with ovarian cancer, and 24 women with benign ovarian cysts or tumors to see if these groups had antibodies to mesothelin. They also compared the three groups of women to healthy women to see if mesothelin antibodies were present.

Significant levels of mesothelin antibodies were found in women with ovarian cancer and in women with unexplained infertility or women who were infertile due to premature ovarian failure or ovulation problems. Women who were infertile due to endometriosis didn't have significant levels of mesothelin antibodies, according to the study. Healthy women, and women with benign ovarian growths also didn't have significant levels of mesothelin antibodies, the investigators found.

"There's a lot more we have to learn, but our aim would be for a screening test that could improve detection," said Luborsky.

More information

Learn more about ovarian cancer from the American Cancer Society.

SOURCES: Judith Luborsky, Ph.D., professor, pharmacology, obstetrics and gynecology, and preventive medicine, and associate dean, research, College of Health Sciences, Rush University Medical Center, Chicago; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; Aug. 17, 2011, Cancer Epidemiology, Biomarkers & Prevention, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Central Catheters May Raise Risk of Blood Clots After Surgery
2. Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat
3. Study finds popular muscle-boosting supplement does not increase blood flow
4. Maternal Blood Test Can Determine Sex of Fetus at 7 Weeks
5. Many Heart Patients Anemic After Too Many Blood Tests in Hospital
6. Researchers find way to help donor adult blood stem cells overcome transplant rejection
7. Another Blood Test for Alzheimers Shows Promise
8. Infrared Detector May Lead Vampire Bat to Blood
9. Johns Hopkins scientists begin first-of-its-kind research to create blood platelets from stem cells
10. Noninvasive fecal occult blood test effective screen for lower GI tract lesions
11. Scientists show swamp gas protects blood vessels from complications of diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Antibody May Signal Start of Ovarian Cancer
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Robert E. ... large medical group. But his impoverished upbringing and life experiences could have led him ... a Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County ... chronic inflammatory gum condition that occurs when the bacteria in plaque infect the gums ... to as a scaling and root planing or SRP, and can include surgical therapies ...
(Date:2/27/2017)... ... 2017 , ... Sunshine Coast Health Centre (SCHC), one of ... https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered massage ... commitment to innovation in drug rehab and alcohol treatment strategies beyond a "punishment" ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards & ... International Social Design Awards. , The 7th A' Social Design Award is ... Institutions worldwide with realized projects and conceptual works. , The first phase of ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017  Today, exocad America and ... have a new path to produce 510(K) cleared, ... implant library integrated into exocad DentalCAD software. In ... compliant Good Manufacturing Processes (GMP,s) into their organization, ... and complete an audit process. Then, dental labs can ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Wireless Health Market is poised to ... to reach approximately $330.5 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Empty Capsules Market is poised to grow at a CAGR ... by 2025. This industry report analyzes the market estimates ... regional levels presented in the research scope. The study provides historical market ...
Breaking Medicine Technology: